Suloctidil - CAS 54767-75-8
Catalog number: 54767-75-8
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C20H35NOS
Molecular Weight:
337.56
COA:
Inquire
Targets:
Na+/K+ ATPase
Description:
Suloctidil is a new drug that effect of suloctidil on Na+/K+ ATPase activity and on membrane fluidity.
Purity:
≥95%
Appearance:
Solid powder
Synonyms:
(1S,2R)-2-(octylamino)-1-(4-propan-2-ylsulfanylphenyl)propan-1-ol;
Solubility:
Soluble in DMSO
Storage:
Store at -20 °C
MSDS:
Inquire
Application:
Na+/K+ ATPase inhibitor
Quality Standard:
Enterprise Standard
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Milligrams-Grams
InChIKey:
BFCDFTHTSVTWOG-YLJYHZDGSA-N
InChI:
1S/C20H35NOS/c1-5-6-7-8-9-10-15-21-17(4)20(22)18-11-13-19(14-12-18)23-16(2)3/h11-14,16-17,20-22H,5-10,15H2,1-4H3/t17-,20-/m1/s1
Canonical SMILES:
CCCCCCCCNC(C)C(C1=CC=C(C=C1)SC(C)C)O
Current Developer:
Continental Pharma
1.A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis.
Butts A1, DiDone L, Koselny K, Baxter BK, Chabrier-Rosello Y, Wellington M, Krysan DJ. Eukaryot Cell. 2013 Feb;12(2):278-87. doi: 10.1128/EC.00314-12. Epub 2012 Dec 14.
New, more accessible therapies for cryptococcosis represent an unmet clinical need of global importance. We took a repurposing approach to identify previously developed drugs with fungicidal activity toward Cryptococcus neoformans, using a high-throughput screening assay designed to detect drugs that directly kill fungi. From a set of 1,120 off-patent medications and bioactive molecules, we identified 31 drugs/molecules with fungicidal activity, including 15 drugs for which direct antifungal activity had not previously been reported. A significant portion of the drugs are orally bioavailable and cross the blood-brain barrier, features key to the development of a widely applicable anticryptococcal agent. Structural analysis of this set revealed a common chemotype consisting of a hydrophobic moiety linked to a basic amine, features that are common to drugs that cross the blood-brain barrier and access the phagolysosome, two important niches of C.
2.The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.
Itil TM1, Eralp E, Ahmed I, Kunitz A, Itil KZ. Psychopharmacol Bull. 1998;34(3):391-7.
In 1994, a standardized dry extract of Ginkgo biloba leaves (SeGb), has been approved by German health authorities for the treatment of primary degenerative dementia and vascular dementia. More than 24 different brands of Ginkgo biloba extract are sold in the United States. Tacrine, also known as tetrahydroaminoacrine (THA), and donepezil are currently the only drugs approved in the United States for the treatment of Alzheimer's disease. Previous studies demonstrated that SeGb and tacrine induce significant pharmacological effects on the brains of young, healthy human males, as determined by bioelectrical activity measurements obtained using the quantitative pharmaco-electroencephalogram (QPEEG) method. The type of central nervous system (CNS) effects we have seen on computer-analyzed EEGs (CEEGs) after administration of tacrine or EGb suggests both are "cognitive activators" which are, as a class of products, characterized by a (prepost) relative increase of 7.
3.Two forms of yeast plasma membrane H(+)-ATPase: comparison of yield and effects of inhibitors.
Lapathitis G1, Kotyk A. Folia Microbiol (Praha). 2000;45(3):221-3.
Classical isolation procedure for plasma membrane H(+)-ATPase of Saccharomyces cerevisiae based on fractional centrifugation yielded always a roughly two-fold greater amount of membranes when starting from glucitol-preincubated than from glucose-preincubated yeast. This difference persisted all the way to the purified plasma membranes and to the purified H(+)-ATPase. The ATP-hydrolyzing activity by plasma membranes was roughly twice greater in glucose-preincubated cells than in the D-glucitol-preincubated ones while the purified enzyme was 7 times more active after glucose than after glucitol. Effects of diethylstilbestrol, suloctidil, erythrosin B, vanadate and dicarbanonaboranuide were very similar on plasma membrane-localized and purified ATPases of both forms, suggesting that both preparations contain the two ATPase forms, the glucose-preincubated one being richer in the activated form while the glucitol-preincubated one contains less of it.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Na+/K+ ATPase Products


CAS 71-63-6 Digitoxin

Digitoxin
(CAS: 71-63-6)

Digitoxin, a cardiac glycoside, is an effective Na+/K+-ATPase inhibitor, the EC50 value of Digitoxin is 0.78 μM that usually comes from the roots of Digitalis p...

CAS 54767-75-8 Suloctidil

Suloctidil
(CAS: 54767-75-8)

Suloctidil is a new drug that effect of suloctidil on Na+/K+ ATPase activity and on membrane fluidity.

CAS 77-52-1 Ursolic acid

Ursolic acid
(CAS: 77-52-1)

Ursolic acid is a natural pentacyclic triterpenoid carboxylic acid displaying antitumor activity. It was shown to downregulate the MMP-2 and uPA expression, and...

CAS 216299-46-6 3β-Amino-3-Deoxydigoxigenin Hemisuccinamide Succinimidyl Ester

3β-Amino-3-Deoxydigoxigenin Hemisuccinam
(CAS: 216299-46-6)

3β-Amino-3-Deoxydigoxigenin Hemisuccinamide Succinimidyl Ester is an amine-reactive derivative of Digoxigenin. It has been shown to inhibit the Na+/K+ ATPase by...

Istaroxime hydrochloride
(CAS: 374559-48-5)

Istaroxime is a adenosine triphosphatase inhibitor, inhibition of sodium/potassium adenosine triphosphatase (Na+/K+ ATPase).

Istaroxime
(CAS: 203737-93-3)

Istaroxime, also called as PST 2744, is an inhibitor of sodium-potassium ATPase that exhibits the unique property of increasing SERCA2a activity. This has been ...

CAS 20449-79-0 Melittin

Melittin
(CAS: 20449-79-0)

Melittin is a polypeptide isolated from the venom of the honey bee (Apis mellifera). It inhibits protein kinase C, Ca2+/calmodulin-dependent protein kinase II, ...

Rostafuroxin
(CAS: 156722-18-8)

Rostafuroxin is a Na+/K+ ATPase modulator that treats hypertension by normalizing renal Na+/K+ ATPase pump function.

Chemical Structure

CAS 54767-75-8 Suloctidil

Quick Inquiry

Verification code

Featured Items